Prognostic factors for visual acuity improvement after intravitreal triamcinolone injection

Eye

Volumn 21, Issue 8, 2007, Pages 1067-1070

  Shulman, S ^a   Ferencz, J R ^a   Gilady, G ^a   Ton, Y ^a   Assia, E ^a  

^a MEIR MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROGNOSIS; PSEUDOPHAKIA; RETINA DEGENERATION; RETINA MACULA CYSTOID EDEMA; RETINA MACULA EDEMA; VEIN OCCLUSION; VISUAL ACUITY;

EID: 34547926682     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702408     Document Type: Article

References (14)

1. Negi AK, Vernon SA, Lim CS, Owen-Armstrong K. Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation. Eye 2005; 19: 747-751.
2. Jonas JB, Degenring RF, Kamppeter BA, Kreissig I, Akkoyun I. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Am J Ophthalmol 2004; 138: 158-160.
3. Bashshur ZF, Ma'luf RN, Allam S, Jurdi FA, Haddad RS, Noureddin BN. Intravitreal triamcinolone for the management of macular edema due to nonischemic central, retinal vein occlusion. Arch Ophthalmol 2004; 122: 1137-1140.
4. to-Pedre E, Hernaez-Ortega MC. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2004, 137: 596.
5. Karacorlu M, Ozdemir H, Karacorlu S. Intravitreal trimcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema. Acta Ophthalmol Scand 2003; 81: 648-652.
6. Karacorlu M, Mudun B, Ozdemir H, Karacorlu SA, Burumeck E. Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behcet disease. Am J Ophthalmol 2004; 138: 289-291.
7. Sutter FK, Gillies MC. Intravitreal triamcinolone for radiation-induced macular edema. Arch Ophthalmol 2003; 121: 1491-1493.
8. Scott IU, Flynn Jr HW, Rosenfeld PJ. Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema. Am J Ophthalmol 2003; 136: 737-739.
9. Gillies MC, Simpson JM, Luo W, Penfold P, Hunyor AB, Chua W et al A randon-dzed clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: One-year results. Arch Ophthalmol 2003; 121: 667-673.
10. Bakri SJ, Beer PM. The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imag 2003; 34: 386-390.
11. Jonas JB, Kreissig I, Degenring RF. Endophthalmitis after intravitreal injection of triamcinolone acetonide. Arch Ophthalmol 2003; 121 1663-1664.
12. Nelson ML, Tennant Mr, Sivalingam A, Regillo CD, Belmont JB, Billson F. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 2003; 23: 686-691.
13. Adamis AP. Is diabetic retinopath an inflammatory disease? Br J Ophthalmol 2002; 86: 363-365.
14. Sutter FK, Simpson JM, Gillies MC. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: Three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 2004; 111: 2044-2049.